Clinical Research Biz Medable Lands $2B Valuation In Series D
Clinical research platform Medable said Tuesday it's now valued at $2.1 billion following its Series D funding round that included Blackstone Growth, Tiger Global and GSR Ventures....To view the full article, register now.
Already a subscriber? Click here to view full article